Compugen (CGEN) Enterprise Value Growth (3y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -108.25% |
| Jun 30, 2025 | 9.53% |
| Dec 31, 2024 | 12.05% |
| Jun 30, 2024 | -11.67% |
| Dec 31, 2023 | 51.35% |
| Jun 30, 2023 | -10.49% |
| Dec 31, 2022 | -3.97% |
| Jun 30, 2022 | -8.37% |
| Dec 31, 2021 | -154.86% |
| Jun 30, 2021 | 9.68% |
| Dec 31, 2020 | -67.11% |
| Jun 30, 2020 | 9.96% |
| Dec 31, 2019 | 2.76% |
| Jun 30, 2019 | 16.46% |
| Dec 31, 2018 | 15.82% |
| Jun 30, 2018 | 23.83% |
| Dec 31, 2017 | -0.42% |
| Jun 30, 2017 | 14.67% |
| Dec 31, 2016 | 28.19% |
| Jun 30, 2016 | 3.74% |
| Dec 31, 2015 | 15.42% |
| Jun 30, 2015 | -43.42% |
| Mar 31, 2015 | -78.80% |
| Dec 31, 2014 | -5.39% |
| Jun 30, 2014 | -57.48% |
| Dec 31, 2013 | -9.82% |
| Sep 30, 2013 | 71.65% |
| Jun 30, 2013 | 4.78% |
| Mar 31, 2013 | 13.61% |
| Dec 31, 2012 | -8.59% |
| Sep 30, 2012 | 73.05% |
| Jun 30, 2012 | -24.06% |